Showing results (1041-1050 of 1,358) with videos related to
Sort By:
Pageof 136
Med (New York, N.Y.)|April 29, 2026
Rethinking the role of synergy calculations in the next century of drug combination discoveryChristian T Meyer, Yunxing Dai, Amy E Pomeroy, et al.Journal of Medicinal Chemistry|February 1, 2008
Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonistsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.Nuklearmedizin. Nuclear Medicine|April 16, 2016
[German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging]Henryk Barthel, Philipp T Meyer, Alexander Drzezga, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 15, 2021
Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID SyndromeAndrea Dressing, Tobias Bormann, Ganna Blazhenets, et al.British Journal of Cancer|August 13, 2009
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 StudyJ W Valle, H Wasan, P Johnson, et al.Radiation Oncology (London, England)|September 23, 2018
Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PETNicole Wiedenmann, Hatice Bunea, Hans C Rischke, et al.Oncotarget|August 11, 2016
Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptideLaurent Jacob, Paul Sawma, Norbert Garnier, et al.Radiation Oncology (London, England)|August 31, 2018
Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PETNicole Wiedenmann, Hatice Bunea, Hans C Rischke, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2018
Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysisNina-Sophie Schmidt-Hegemann, Christian Stief, Tak-Hyun Kim, et al.Bioorganic & Medicinal Chemistry Letters|September 4, 2012
Benzimidazoles as benzamide replacements within cyclohexane-based CC chemokine receptor 2 (CCR2) antagonistsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.Pageof 136